+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability

The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability

Hepatology 7(3): 452-456

The role of changes in blood-brain barrier permeability in the pathogenesis of hepatic encephalopathy remains uncertain. To test the hypothesis that brain microvessel permeability is nonselectively increased in hepatic encephalopathy we measured the blood-brain barrier permeability-surface area product in rats with acute liver failure induced by intraperitoneal injection of galactosamine. The permeability-surface area products to the diffusion-limited tracers, sucrose and methylaminoisobutyric acid, were determined as a measure of blood-brain barrier permeability. Animals were examined 24, 36 and 42 hr after injection, at times when they were stuporous, but not comatose. No significant elevations of the permeability-surface area products for either compound were detected in clinically affected experimental animals when compared to controls. Our results indicate there is no generalized increase in brain vascular permeability during hepatic insufficiency in precomatose animals.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 041639415

Download citation: RISBibTeXText

PMID: 3570156

DOI: 10.1002/hep.1840070307

Related references

Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport. Journal of Hepatology 6(2): 187-192, 1988

Functional and ultrastructural changes of blood-brain barrier in rats with D-galactosamine-induced fulminant hepatic failure. Hepatology 16(4 Part 2): 271A, 1992

Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 7(6): 1272-1277, 1987

An electron microscopic histochemical study of the blood-brain barrier in acute hepatic failure induced by D-galactosamine. Nihon Ika Daigaku Zasshi 54(3): 290-299, 1987

Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. Asaio Transactions 36(1): 21-27, 1990

Experimental studies of blood brain barrier permeability in acute hepatic failure. Hepatology 4(3): 359-363, 1984

Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver International 34(3): 353-361, 2014

Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model. Biomaterials Artificial Cells and Artificial Organs 15(3): 559-573, 1987

Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure. Journal of Investigative Surgery 21(3): 101-108, 2008

Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [ 14 C] and [ 13 C]sucrose. Metabolic Brain Disease 32(6): 1903-1912, 2017

Potential toxins of acute liver failure and their effects on blood-brain barrier permeability. Experientia 39(9): 988-991, 1983

Tumor necrosis factor-α affects blood-brain barrier permeability in acetaminophen-induced acute liver failure. European Journal of Gastroenterology and Hepatology 23(7): 552-558, 2011

Hepatic failure effects on transcellular membrane vesicular traffic in the blood brain barrier of rabbits. Pediatric Research 20(4 Part 2): 245A, 1986

Electron microscopy of the brain in rabbits with galactosamine induced fulminant hepatic failure. Clinical Research 34(4): 953A, 1986

Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. Biomaterials Artificial Cells and Immobilization Biotechnology 19(3): 565-577, 1991